Investor Presentation for the month of February, 2026.
TRANSPEK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Transpek Industry reported Q3 FY26 revenue of ₹162.0 crore, down 7.4% YoY, with EBITDA margins expanding 109 bps to 17.6%. For 9M FY26, revenue stood at ₹493.2 crore (down 2.4% YoY) but EBITDA grew 14.9% to ₹95.9 crore with margins improving 294 bps to 19.4%, and PAT rose 32.5% to ₹39.1 crore. Management guided average expected EBITDA margins in the 16%–20% range, depending on product mix and pricing. The company is evaluating capex for new products, expanding into Eurasia and South America, and expects the US trade deal and EU–India FTA to open new opportunities. Transpek also received the EcoVadis Gold Medal for sustainability and a 200% dividend for FY25.
Margin expansion and PAT growth remain strong despite modest revenue softness, supported by global trade deals and geographic expansion. The EBITDA margin guidance of 16%–20% reinforces profitability focus, while new product commercialisation in 2026–27 and capex decisions are key near-term triggers for investors.